Zenlabs Ethica Ltd Share Price & Stock Analysis

Zenlabs Ethica Ltd (BSE: 530697) is a Chandigarh-based company in the Health Care Distributors industry. With a market capitalisation of ₹19 Cr, it ranks #4,474 by market cap among the 6,197 Indian listed companies on FinBizNet, and #6 of 11 in Health Care Distributors. At ₹28.00 (as of 16 Nov 2026), the share price is 30.0% below its 52-week high of ₹39.99 and 69.7% above its 52-week low of ₹16.50. The share price is down 12.5% over one year and up 6.7% over three months.

Key Metrics

Current Price₹28.00
Market Cap₹19 Cr
BSE Code530697
SectorHealth Care > Health Care Equipment and Services > Health Care Providers and Services
Sub-IndustryHealth Care Distributors
P/E RatioNot meaningful (loss)
Return on Equity-20.44%
Return on Assets1.43%
52-Week Range₹16.50 – ₹39.99
1-Year Price Change-12.5%
3-Month Price Change+6.7%
Beta (1Y)0.8
Dividend Yield0.00%
HeadquartersChandigarh
Websitewww.zenlabsethica.com

Shareholding and Delivery

Delivery averaged 78.9% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Zenlabs Ethica Ltd

Zenlabs Ethica Limited markets and distributes pharmaceutical products primarily in India. It markets analgesics and anti-inflammatory drugs; skin preparations; drugs for neurological and GIT disorders; ear, eye, and nasal drops; anti-diabetic, anti-depressant, anti-infective, anti-emetic, anti-hypertensive, anti-allergic, and anti-cold and cough syrups; steroids and anabolic steroids; nutraceuticals; antacids, enzymes, and appetite stimulants; ayurvedic preparations; soaps; dusting powders; soaps; and other pharmaceutical drugs. The company is also involved in the private label manufacturing of various pharmaceutical products, such as tablets, capsules, injections, syrups, and ointments; and therapeutics, such as anti-infective, anti-obesity, anti-bacterial, anti-hypertensives, anti-fungal, pain killers, and nutritional supplements. It serves customers through a network of distributors and stockists in Myanmar, Indonesia, Malaysia, Thailand, Cambodia, Vietnam, Laos, the Philippines, S

Products and Services

1. Trading of Pharmaceuticals Formulation-This segment engages in the trade of pharmaceutical products.

Business Segments

1. Pharmaceuticals Formulation-100%

Zenlabs Ethica Ltd vs Peers — Health Care Distributors

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Trimurthi Ltd₹197 Cr57.67.99%—+33.3%
Achyut Healthcare Ltd₹191 Cr609.20.95%—+39.7%
Vaidya Sane Ayurved Laboratories₹148 Cr—13.40%—-46.6%
Balaxi Pharmaceuticals Ltd₹125 Cr92.20.59%₹81 Cr-44.5%
Medico Intercontinental Ltd₹25 Crn/m-27.14%₹14 Cr-31.5%
Zenlabs Ethica Ltd₹19 Crn/m-20.44%—-12.5%
Rubra Medicaments Ltd.₹18 Cr12.212.67%—-53.2%
Nexus Surgical & Medicare Ltd₹15 Cr2051.41%—+76.5%
Brawn Biotech Ltd.₹7 Cr724.43%—+9.4%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd is trading at ₹28.00, with a market capitalisation of ₹19 Cr.

Which sector does Zenlabs Ethica Ltd belong to?

Zenlabs Ethica Ltd operates in the Health Care > Health Care Equipment and Services > Health Care Providers and Services space (Health Care Distributors).

What are the key financial ratios of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd has a return on equity of -20.44%.

What is the stock symbol of Zenlabs Ethica Ltd?

Zenlabs Ethica Ltd is listed on the BSE under the scrip code 530697.

How has Zenlabs Ethica Ltd's share price moved over the past year?

Zenlabs Ethica Ltd's share price is down 12.5% over one year and up 6.7% over three months. Its 52-week range is ₹16.50 to ₹39.99.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.